^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    RD125

    i
    Other names: RD125, CT125A cells, fully human anti-CD5 chimeric antigen receptor T cells, CT125A CAR-T cells, RD-125, RD 125
    Associations
    News
    Trials
    Company:
    IASO BIO
    Drug class:
    CD5-targeted CAR-T immunotherapy
    Related drugs:
    Associations
    News
    Trials